| Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients AF Ogata, CA Cheng, M Desjardins, Y Senussi, AC Sherman, M Powell, ... Clinical Infectious Diseases 74 (4), 715-718, 2022 | 225 | 2022 |
| Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier LM Yonker, T Gilboa, AF Ogata, Y Senussi, R Lazarovits, BP Boribong, ... The Journal of Clinical Investigation 131 (14), 2021 | 211 | 2021 |
| Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae Z Swank, Y Senussi, Z Manickas-Hill, XG Yu, JZ Li, G Alter, DR Walt Clinical Infectious Diseases 76 (3), e487-e490, 2023 | 194 | 2023 |
| Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis LM Yonker, Z Swank, YC Bartsch, MD Burns, A Kane, BP Boribong, ... Circulation 147 (11), 867-876, 2023 | 136 | 2023 |
| Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae Z Swank, Y Senussi, G Alter, DR Walt Medrxiv, 2022 | 114 | 2022 |
| Reverse transcriptase inhibition disrupts repeat element life cycle in colorectal cancer M Rajurkar, AR Parikh, A Solovyov, E You, AS Kulkarni, C Chu, KH Xu, ... Cancer discovery 12 (6), 1462-1481, 2022 | 30 | 2022 |
| Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies JL Crombie, AC Sherman, CA Cheng, CE Ryan, R Zon, M Desjardins, ... Blood Advances 5 (16), 3062-3065, 2021 | 22 | 2021 |
| Zonulin antagonist, larazotide (AT1001), as an adjuvant treatment for multisystem inflammatory syndrome in children: a case series LM Yonker, Z Swank, T Gilboa, Y Senussi, V Kenyon, L Papadakis, ... Critical care explorations 4 (2), e0641, 2022 | 20 | 2022 |
| Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multicancer biomarker MS Taylor, C Wu, PC Fridy, SJ Zhang, Y Senussi, JC Wolters, T Cajuso, ... Cancer discovery 13 (12), 2532-2547, 2023 | 18 | 2023 |
| Analytic sensitivity of the Abbott BinaxNOW™ lateral flow immunochromatographic assay for the SARS-CoV-2 Omicron variant S Kanjilal, S Chalise, AS Shah, CA Cheng, Y Senussi, M Springer, ... Medrxiv, 2022.01. 10.22269033, 2022 | 10 | 2022 |
| Immunogenicity of a three-dose primary series of mRNA COVID-19 vaccines in patients with lymphoid malignancies AC Sherman, JL Crombie, CA Cheng, M Desjardins, G Zhou, ... Open forum infectious diseases 9 (8), ofac417, 2022 | 6 | 2022 |
| Performance of three rapid antigen tests against the SARS-CoV-2 Omicron variant S Kanjilal, S Chalise, AS Shah, CA Cheng, Y Senussi, R Uddin, ... medRxiv, 2022.02. 17.22271142, 2022 | 4 | 2022 |
| Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection MJ Peluso, ZN Swank, SA Goldberg, S Lu, T Dalhuisen, E Borberg, ... medRxiv, 2023 | 3 | 2023 |
| Plasma-based antigen persistence in the post-acute phase of COVID-19 MJ Peluso, ZN Swank, SA Goldberg, S Lu, T Dalhuisen, E Borberg, ... The Lancet Infectious Diseases, 2024 | | 2024 |
| High Frequency of Prior SARS-CoV-2 Infection by Sensitive Nucleocapsid Assays JP Nkolola, J Liu, AY Collier, C Jacob-Dolan, Y Senussi, E Borberg, ... The Journal of Infectious Diseases, jiae174, 2024 | | 2024 |
| Ultrasensitive Detection of SALL4 Oncoproteins in Peripheral Blood and Bone Marrow Aspirate: Companion Diagnostics and Therapeutic Monitoring S Shah, J Liu, Y Senussi, A Melkonian, J Nuhfer, S Lovitch, N Lindeman, ... Blood 142, 6049, 2023 | | 2023 |
| Development of a Companion Diagnostic for a Targeted Protein Degradation Therapy: Ultrasensitive and Minimally-Invasive Detection of SALL4 Oncoproteins for Therapeutic Monitoring J Liu, Y Senussi, A Melkonian, DR Walt, L Chai American Journal of Clinical Pathology 160 (Supplement_1), S89-S90, 2023 | | 2023 |
| Heterotypic responses against nsp12/nsp13 from prior SARS-CoV-2 infection associates with lower subsequent endemic coronavirus incidence DJ Bean, J Monroe, YM Liang, E Borberg, Y Senussi, Z Swank, S Chalise, ... bioRxiv, 2023 | | 2023 |
| Reply to Alaedini and Wormser Z Swank, Y Senussi, Z Manickas-Hill, XG Yu, JZ Li, G Alter, DR Walt Clinical Infectious Diseases 76 (7), 1342-1343, 2023 | | 2023 |
| 24. Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients M Powell, AC Sherman, J Klopfer, M Desjardins, CA Cheng, Y Senussi, ... Open forum infectious diseases 8 (Supplement_1), S16-S17, 2021 | | 2021 |
